and is elevated by the addition of Cohn's fraction IV, freed of lipoproteins, to the growth medium.
Histochemical examination of L929 fibroblasts indicates massive accumulation of intracellular lipids in cells grown in medium supplemented with 10% calf serum. The present study suggests that the accumulation of triacylglycerols in these cells may be due to the inhibition of acid lipase activity by a serum component present in the culture medium. This is based on the following observations. (a) Acid lipase appears to be the major intracellular enzyme responsible for triacylglycerol catabolism in L929 cells. (b) The acid lipase is strongly inhibited by either human of calf serum. Several lines of evidence show that the inhibitor is a serum protein: it is heat-labile, non-dialysable and is destroyed by trypsin. It is present mainly in Cohn's fraction IV and has mol.wt. approx. 50000. (c) Lipid accumulation in intact cells is reduced when cells are grown on a limited supply of serum (2%) and is elevated by the addition of Cohn's fraction IV, freed of lipoproteins, to the growth medium.
Triacylglycerols in cultured fibroblasts are known to be derived from several sources: synthesis from glucose de novo; incorporation of non-esterified fatty acids from the medium; uptake of intact triacylglycerol molecules (Geyer, 1967; Mackenzie et al., 1967; Moskowitz, 1967 ; Klintworth & Hijmans, 1970; Baily et al., 1973) .
In cultures of L929 fibroblasts, incorporated triacylglycerols were shown to be further metabolized and converted into other cell glycerolipids (Baily et al., 1973) . Studies with double-labelled triacylglycerols indicated that the conversion of triacylglycerols into phospholipids occurs with the conservation of both glycerol and non-esterified fatty acid moieties (Baily et al., 1973) , presumably via the diacylglycerol pathway (Hokin & Hokin, 1959) . Hydrolysis of the incorporated triacylglycerols to non-esterified fatty acids was found to be a relatively minor process (Baily et al., 1973 (Nilsson-Ehle & Schotz, 1976) . The fatty acids liberated were separated and determined by the method of Belfrage & Vaughan (1969) . The release of fatty acids under these conditions is linear with regard to incubation time and amount of enzyme. Inclusion of excess amounts of lecithin up to 0.4 mg/assay did not affect the lipase assay system.
Preparation ofdelipidized serum
Delipidized human serum proteins were prepared by the method of Rothblat et al. (1976 Ciechanover et al. (1978) and in the presence or absence of the inhibitor as specified, in a total volume of 100ul at 300C for 30min. The reaction was stopped by the addition of 10mg of albumin followed by the addition of 0.9 ml of 10% trichloroacetic acid. Radioactivity in the soluble nonprecipitable fraction was measured. ac-Antitrypsin, partially purified from human plasma, was obtained from Sigma Chemical Co.
Triacvlglvcerol determination
The triacylglycerols were split by saponification and the glycerol moiety was enzymically determined. Triacylglycerols were specifically extracted from cellular lipids as described by Dole & Meinertz (1960) . The upper phase was evaporated to dryness in a stream of N2 and redissolved in a small volume of light petroleum (b.p. 60-80°C). The samples were incubated with 0.5 ml of alcoholic 0.5 M-KOH at 65°C for 45min. After cooling, 1.0ml of 0.15M-MgSO4 was added, the samples were centrifuged and the clear solution served for glycerol determination. The assay system for glycerol determination contained, in 1.0 ml, 0.1 M-triethanolamine/0.004 MMgSO4 buffer, pH 7.6, 0.15,uM-NADH, 1.65,UM-ATP, 0.55,uM-phosphoenolpyruvate, 20,ug of lactate dehydrogenase and 10,ug of pyruvate kinase. The reaction was started by the addition of 20,ug of glycerol kinase and the change in the absorbance at 340nm was measured in a Gilford spectrophotometer (model 2400-S).
Protein was determined by the method of Lowry etal. (1951) .
Results
L929 fibroblasts grown in a medium supplemented with 10% calf serum show a remarkable accumulation of intracellular lipids. Fig. 1 illustrates a typical histochemical appearance of logarithmically dividing L929 fibroblasts, stained with Oil Red 0. Identical micrographs were observed in about 20 independent cultures grown under the same conditions. As can be seen, lipids accumulated within the cells in a typical morphological pattern. The possibility that lipid accumulation in these cells is a result of the uptake of lipoproteins from the medium is unlikely, since similar results were observed when L929 cells were grown on medium containing 10% calf serum from which lipoproteins were previously removed by ultracentrifuge flotation.
An alternative possibility that fat accumulation in L929 fibroblasts is due to enhanced uptake of fatty acids is also unlikely. Similar rates of incorporation of fatty acids were observed in fat-accumulating L929 cells and in 3T3 cells, which do not accumulate lipids (results not shown).
The following experiments were designed to determine whether the fat accumulation in L929 cells is due to any defect in the lipolytic activity of these cells.
Acetone-dried powders prepared from cultured L929 fibroblasts were assayed for lipolytic activity. Fig. 2 depicts a typical result obtained in one of four independent preparations. It is clear that the cell extract contained two distinguishable lipolytic activities. These are an acid lipase with pH optimum of 4.4 and an alkaline lipase activity with pH optimum at about 8.5. No neutral pH activity could be detected in these cells.
The acid lipase activity was found to be markedly inhibited by serum. Fig. 3 shows that the addition of as little as 5,ul of either calf or fasted-human serum to the assay mixture caused an about 50% reduction of lipolytic activity. Similar results were repeatedly obtained in five separate experiments. To define the serum component responsible for the inhibition of acid lipase activity, fasted-human serum was treated by different procedures as described below, before its addition to the lipase assay. As shown in Table 1 , serum dialysed overnight against phosphate-buffered saline (pH 7.2) retained all the inhibitory activity. Boiling the serum for 5min abolished most of the inhibition. These results indicated that the acid lipase inhibitor present in the serum is either of a protein nature or is a component attached to the serum proteins.
The possible involvement of a serum lipid component attached to protein in the acid lipase inhibition in vitro was ruled out by the finding that the removal of serum lipoproteins by ultracentrifuge flotation failed to affect inhibitory activity (Table 1) . This procedure leaves non-esterified fatty acids bound to serum albumin. We therefore examined the effect of solvent-delipidized serum on the lipase activity.
Human serum was treated with acetone/ethanol (1: 1, v/v) and serum proteins were then dissolved in buffer to the same protein concentration as in the original serum. As shown in Table 1 , this fraction, too, retained all the inhibitory activity present in the serum. These results clearly excluded any lipid component present in the serum from being responsible for the inhibitory effect of serum on acid lipase.
The possibility that the serum inhibitor is a protein component was further examined by the addition of trypsin-treated serum to the acid lipase assay. The highest specific activity of the inhibitor was located in Cohn fraction IV. The combined fractions I-III seem to contain much less inhibitor protein, and fraction V had no inhibitor activity (Table 2) .
Fraction IV was freed from lipoproteins by ultracentrifuge flotation and dialysed overnight against 0.9% NaCl. This fraction, which retained most of the inhibitor activity, was then applied to a column of Sepharose-6B equilibrated with 0.1 MTris/HCl buffer, pH 8.0, containing 0.1 M-NaCl. The eluate was monitored by absorption at 280nm. As shown in Fig. 5 , the inhibitor was eluted in a single peak with an estimated mol.wt. of 50000.
Since serum a1-antitrypsin inhibitor, which has about the same molecular weight, is also precipitated in Cohn fraction IV, we examined the possibility that these two inhibitors are similar.
The ratio of lipase inhibitor/antitrypsin activity in Cohn fraction IV was compared with that of a partially purified preparation of a,-antitrypsin (Sigma Chemical Co.). The significant difference in the activity ratio between the two preparations shown in Table 3 favours the notion that the two inhibitors are distinct protein entities.
The question arises whether the presence of the acid lipase inhibitor in the growth medium may affect lipid breakdown within the intact cells and thus cause fat accumulation. Histochemical observations illustrated in Fig. 6 show that reduction in the amount of the inhibitor in the growth medium by decreasing the serum concentration from 10% to 2% only, almost abolishes the fat accumulation in the intact cells (Figs. 6a and 6b) . These results are in accord with chemical determinations of the triacylglycerol content in these cells (Table 4) . Furthermore, when lipoprotein-free fraction IV was added to the growth medium containing 2% serum, the cells started again to accumulate a remarkable amount of fat ( Fig. 6c and Table 4 ).
These experiments in vivo suggest a possible relationship between intracellular fat accumulation and the presence of the acid lipase inhibitor in the growth medium.
An attempt was made to examine whether enzyme derived from cells grown in 10% serum was already inhibited. Acid lipase activities extracted from three separate cultures of cells grown in medium containing either 2% or 10% serum were 33+6.7 nmol of fatty acid/mg of protein and 29 + 5 nmol of fatty acid/mg of protein (means + S.D.) respectively. Thus no difference could be discerned in activities of an acetone-dried powder preparation of acid lipase from cells exposed to high or low serum concentration.
Final conclusions on the possibility of complexformation between enzyme and inhibitor must await full purification of the inhibitor, however. 2% serum + fraction IV (0.9 mg/ml) 11.94 ± 0.083 (5)
Discussion
The results demonstrate that L929 fibroblasts grown on medium supplemented with 10% calf serum accumulate massive amounts of intracellular lipids.
A high content of lipids was also found in 3T3-L1 fibroblasts, a sub-line capable of being differentiated into adipocyte-like cells (Green & Kehinde, 1974) . However, the morphological lipid distribution in the two cell types is completely different.
The histochemical pattern of lipid accumulation in L929 cells resembles that found in human skin fibroblasts from patients with a genetic deficiency of acid lipase (Kyriakides et al., 1972; Cortner et al., 1976 (Mahadevan & Tappel, 1968; Hayase & Tappel, 1970) . In cultured human fibroblasts, as in L929 fibroblasts, acid lipase plays a major role in the catabolism of intracellular triacylglycerols. In these cells too, neutral lipase activity, if it exists, is on the borderline of detectability (Beaudet et al., 1974) .
Contrary to L929 fibroblasts and to human fibroblasts, Littlefield L mouse fibroblasts and 3T3 cells, which do not accumulate lipid, contain considerable neutral lipase activity (Lengle & Geyer, 1973; Adebonojo et al., 1977 In the intact cells, inhibition of acid lipase activity by the serum protein requires its introduction to the intracellular environment, presumably to the lysosomal fraction where acid lipase is located (Mahadevan & Tappel, 1968) . Very little information is currently available on protein uptake by fibroblasts. Uptake of intact low-density lipoproteins by fibroblasts has been reported (Goldstein & Brown, 1977) . To clarify the physiological role of the protein inhibitor, it remains to be established whether the inhibitor protein can be taken up by 1982 Fraction IV a1-Antitrypsin these cells. A further problem is that if the inhibitor is endocytosed, is it resistant enough to the action of lysosomal proteinases to exert its effect within the lysosome.
As mentioned above, the inhibitor protein present in the serum affects acid lipase activity from various tissues. Fat accumulation in different cell types might depend, therefore, on the ability of the inhibitor to be taken up by the cell, and on the presence of additional lipases within the cells that are not affected by the inhibitor.
The physiological significance of the presence of an active acid lipase inhibitor in normal serum remains to be determined.
